These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74. Relapsing rash and depression: A case study. Due K Aust Fam Physician; 2016 Apr; 45(4):197-8. PubMed ID: 27052134 [No Abstract] [Full Text] [Related]
76. Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta-analysis. Xu L; Yu H; Xu S; Wang Y; Cao Y Skin Res Technol; 2024 May; 30(5):e13749. PubMed ID: 38776128 [TBL] [Abstract][Full Text] [Related]
77. Atypical Presentation of Sjogren's Syndrome With Chronic Urticaria: A Case Report and Literature Review. Ahmad U; Waseem T; Logee K Cureus; 2023 Mar; 15(3):e35809. PubMed ID: 37033579 [TBL] [Abstract][Full Text] [Related]
78. Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy. Betterle C; Furmaniak J; Sabbadin C; Scaroni C; Presotto F J Endocrinol Invest; 2023 Apr; 46(4):643-665. PubMed ID: 36609775 [TBL] [Abstract][Full Text] [Related]
79. Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes. Yen FS; Hsu CC; Hu KC; Hung YT; Hsu CY; Wei JC; Hwu CM Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078769 [TBL] [Abstract][Full Text] [Related]